Summit Securities Group’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-132
Closed -$8.43K 1138
2025
Q4
$8.43K Sell
132
-66
-33% -$4.07K ﹤0.01% 903
2025
Q3
$12.5K Sell
198
-1,699
-90% -$119K ﹤0.01% 851
2025
Q2
$142K Buy
+1,897
New +$149K 0.03% 304
2023
Q3
Sell
-156
Closed -$13K 697
2023
Q2
$13K Sell
156
-78
-33% -$6.34K ﹤0.01% 735
2023
Q1
$20K Sell
234
-3,586
-94% -$308K ﹤0.01% 626
2022
Q4
$311K Buy
3,820
+3,417
+848% +$275K 0.01% 360
2022
Q3
$29K Buy
403
+133
+49% +$12K ﹤0.01% 678
2022
Q2
$24K Buy
270
+217
+409% +$22.5K ﹤0.01% 728
2022
Q1
$6K Buy
+53
New +$6.21K ﹤0.01% 931
2018
Q1
Sell
-2,400
Closed -$222K 176
2017
Q4
$222K Buy
+2,400
New +$218K 0.03% 151
2015
Q4
Sell
-700
Closed -$45K 326
2015
Q3
$45K Hold
700
0.03% 169
2015
Q2
$57K Buy
+700
New +$54K 0.03% 170
2014
Q4
Sell
-900
Closed -$71.2K 636
2014
Q3
$73K Buy
900
+800
+800% +$66.8K 0.02% 341
2014
Q2
$9K Buy
+100
New +$8.69K ﹤0.01% 412

Other funds holding EMN

Summit Securities Group's EMN Position: Q1 2026 in Review

Summit Securities Group sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 132 shares — an estimated $8.43K sold.

Summit Securities Group first reported a position in EMN in Q2 2014 and held it in 14 quarters. The position peaked at $311K in Q4 2022. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Summit Securities Group reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
  • Summit Securities Group sold 132 Eastman Chemical shares in Q1 2026, an estimated $8.43K.
  • Summit Securities Group first reported a position in Eastman Chemical in Q2 2014 and held it in 14 quarters.
  • Summit Securities Group's Eastman Chemical position peaked at $311K in Q4 2022.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.